Reduced β‐cell mass, decreased β‐cell number, β‐cell dysfunction, or a combination of all three contributes to the ensuing hyperglycemia that defines GDM which underscores the inability of β‐cells to adequately respond to the increasing insulin resistance of pregnancy by releasing a sufficient amount of insulin [1]. This evidence concerns the gene INS and gestational diabetes.